Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Sexual Medicine

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1743-6109.2010.02164.xPMID 21235716PMCID PMC3557497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Penile rehabilitation protocol after robot‐assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency

  2010cited by this paper
• 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME).

  2009cited by this paper
• Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.

  2008cited by this paper
• Association of Single Nucleotide Polymorphisms in SOD2, XRCC1 and XRCC3 with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer

  2008cited by this paper
• Long‐term treatment of erectile dysfunction with a phosphodiesterase‐5 inhibitor and dose optimization based on nocturnal penile tumescence

  2008cited by this paper
• Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

  2008cited by this paper
• Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial.

  2007cited by this paper
• Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy.

  2007cited by this paper
• Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.

  2007influential reference
• Clinical practice. Erectile dysfunction.

  2007cited by this paper
• Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences.

  2006cited by this paper
• Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

  2006cited by this paper
• Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.

  2006cited by this paper
• Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

  2005cited by this paper
• Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02

  2004cited by this paper
• Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.

  2004cited by this paper
• Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study.

  2003cited by this paper
• Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

  2003cited by this paper
• Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

  2002cited by this paper
• A dose‐escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction

  2001cited by this paper
• Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy.

  2001influential reference
• Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study.

  2001cited by this paper
• Unusual case report: Nonpharmacologic effects of sildenafil.

  2000cited by this paper
• Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

  2000cited by this paper
• SILDENAFIL CITRATE (VIAGRA®) IS EFFECTIVE AND WELL TOLERATED FOR TREATING ERECTILE DYSFUNCTION OF PSYCHOGENIC OR MIXED AETIOLOGY

  2000cited by this paper
• Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.

  1999influential reference
• Partners' perceptions of the efficacy of sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.

  1999cited by this paper
• Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer.

  1999influential reference
• Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate.

  1999influential reference
• Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction.

  1999cited by this paper
• Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells.

  1998cited by this paper
• The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

  1997cited by this paper
• On life satisfaction in male erectile dysfunction

  1997cited by this paper
• Quality of Life and Cost Effectiveness Outcomes of Androgen Deprivation Therapy for Prostate Cancer

  1997cited by this paper
• The managed care contract: implementation in radiation oncology.

  1996cited by this paper
• Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

  1996cited by this paper
• A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer.

  1996cited by this paper
• Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours.

  1993cited by this paper
• Marginal modeling of binary cross-over data.

  1993cited by this paper
• Sex therapy for erectile dysfunction: Characteristics of couples, treatment outcome, and prognostic factors

  1992cited by this paper
• Development of the sexual adjustment questionnaire.

  1986cited by this paper
• Factors of Marital Adjustment in Locke's Marital Adjustment Test.

  1974cited by this paper
• The randomization and stratification of patients to clinical trials.

  1974cited by this paper

• A controlled study of use and effectiveness of phosphodiesterase-5 inhibitors in long-term survivors after curative radiotherapy for prostate cancer (PCa).

  2024cites this paper
• Current Knowledge on Radiation-Therapy-Induced Erectile Dysfunction in Prostate-Cancer Patients: A Narrative Review

  2023cites this paper
• Sexual dysfunctions in breast cancer patients: evidence in context.

  2023cites this paper
• Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer

  2023cites this paper
• Canadian Urological Association guideline: Erectile dysfunction.

  2021cites this paper
• Management of late adverse effects after chemoradiation for anal cancer

  2021cites this paper
• Penile Rehabilitation and Treatment Options for Erectile Dysfunction Following Radical Prostatectomy and Radiotherapy: A Systematic Review

  2021cites this paper
• Sexual function in men undergoing androgen deprivation therapy

  2021cites this paper
• Introduction to erectile dysfunction

  2021cites this paper
• Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials

  2020cites this paper
• Prostatic irradiation-induced sexual dysfunction: a review and multidisciplinary guide to management in the radical radiotherapy era (Part I defining the organ at risk for sexual toxicities).

  2020cites this paper
• Toxicity Management for Pelvic Tumors in Radiation Oncology

  2020cites this paper
• Evaluation of effectiveness of antiandrogen treatments on cavernosal tissues in rats

  2020cites this paper
• Prevention and Management of Acute and Late Toxicities in Radiation Oncology: Management of Toxicities in Radiation Oncology

  2020cites this paper
• Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer

  2020cites this paper
• A Systematic Review of the Role of Penile Rehabilitation in Prostate Cancer Patients Receiving Radiotherapy and Androgen Deprivation Therapy.

  2019cites this paper
• Sildenafil Protects Endothelial Cells From Radiation-Induced Oxidative Stress

  2019cites this paper
• Techniques for Reducing Toxicity After SBRT

  2018cites this paper
• Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer.

  2018cites this paper
• Erectile Dysfunction: AUA Guideline

  2018cites this paper
• Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.

  2017cites this paper
• OXGR1 overexpression as putative prostate cancer promoting factor

  2017cites this paper
• Current Status of Targeted Radioprotection and Radiation Injury Mitigation and Treatment Agents: A Critical Review of the Literature.

  2017cites this paper
• Pelvic Radiation and Normal Tissue Toxicity.

  2017cites this paper
• The Diagnosis and Treatment of Prostate Cancer: A Review

  2017cites this paper
• Interventions to address sexual problems in people with cancer.

  2017cites this paper
• How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?

  2017cites this paper
• Cancer, Benign Gynecology, and Sexual Function--Issues and Answers.

  2016cites this paper
• Radiation with Hormonal Therapy

  2016cites this paper
• Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer

  2015cites this paper
• Radiotherapy for prostate cancer and sexual health

  2015cites this paper
• Sexual Difficulties after Pelvic Radiotherapy: Improving Clinical Management.

  2015cites this paper
• Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?

  2014cites this paper
• Methodological considerations in the design and implementation of clinical trials.

  2014influential citation
• Sexual Function in Elderly Men Receiving Androgen Deprivation Therapy (ADT).

  2014cites this paper
• Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer

  2014cites this paper
• Radioterapia externa en el tratamiento del cáncer de próstata localizado: Optimización de la ratio terapéutica

  2014cites this paper
• Nurse scientists in cancer cooperative groups.

  2014cites this paper
• Pelvic radiotherapy and sexual function in men and women.

  2013cites this paper
• Sexual function and male cancer

  2013cites this paper
• Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy.

  2013cites this paper
• A randomised, double‐blind, placebo‐controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer

  2013cites this paper
• Potency preservation following stereotactic body radiation therapy for prostate cancer

  2013cites this paper
• Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase

  2013cites this paper
• The Influence of Cancer Fatalism and Prostate Cancer Knowledge on Sexual Function and Bother after Treatment for Prostate Cancer: A Moderation Model to Explain Ethnic Differences

  2012cites this paper
• [The impact of radiation therapy on sexual function].

  2012cites this paper
• Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy

  2012cites this paper
• Androgen deprivation therapy in prostate cancer: focusing on sexual side effects.

  2012cites this paper
• evue générale mpact de la radiothérapie sur la vie sexuelle mpact of radiation therapy on sexual life

  2012cites this paper
• Phosphodiesterase-5 Inhibitors Could Be Efficacious in the Treatment of Erectile Dysfunction after Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis

  2012cites this paper
• Influence of vascular comorbities and race on erectile dysfunction after prostate cancer radiotherapy.

  2012cites this paper
• Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer

  2012cites this paper
• Role of oxidative stress in a rat model of radiation-induced erectile dysfunction.

  2012cites this paper
• Current world literature.

  2012cites this paper
• Radiotherapy and short-term androgen deprivation for localized prostate cancer.

  2011cites this paper
• Reports of Practical Oncology and Radiotherapy

  year unknowncites this paper